Mouse strain- and age-dependent effects of binge methamphetamine on dopaminergic signaling

NeuroToxicology

Volumn 32, Issue 6, 2011, Pages 751-759

  Good, Renee L ^a   Liang, Li Ping ^a   Patel, Manisha ^a   Radcliffe, Richard A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Age; Dopamine; Methamphetamine; Strain survey; Tyrosine hydroxylase

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; METHAMPHETAMINE; TYROSINE 3 MONOOXYGENASE;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC TRANSMISSION; GENOTYPE; IMMUNOREACTIVITY; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE; STRIATE CORTEX;

3,4-DIHYDROXYPHENYLACETIC ACID; AGE FACTORS; AMPHETAMINE-RELATED DISORDERS; ANIMALS; BASAL GANGLIA; CENTRAL NERVOUS SYSTEM STIMULANTS; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE AGENTS; DOWN-REGULATION; GENOTYPE; MALE; METHAMPHETAMINE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, INBRED DBA; PHENOTYPE; PREFRONTAL CORTEX; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; TIME FACTORS; TYROSINE 3-MONOOXYGENASE;

MUS;

EID: 80055081111     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2011.07.005     Document Type: Article

References (46)

1. Açikgöz O., Gönenç S., Kayatekin B.M., Pekçetin C., Uysal N., Dayi A., Semin I., Güre A. The effects of single dose of methamphetamine on lipid peroxidation levels in the rat striatum and prefrontal cortex. Eur Neuropsychopharmacol 2000, 10:415-418.
2. Boehme R.E., Ciaranello R.D. Genetic control of dopamine and serotonin receptors in brain regions of inbred mice. Brain Res 1983, 266:51-65.
3. Cabib S., Giardino L., Calza L., Zanni M., Mele A., Puglisi-Allegra S. Stress promotes major changes in dopamine receptor densities within the mesoaccumbens and nigrostriatal systems. Neurosci 1998, 84:193-200.
4. Cadet J.L., Brannock C. Free radicals and the pathobiology of brain dopamine systems. Neurochem Int 1998, 32:117-131.
5. Centonze D., Gubellini P., Usiello A., Rossi S., Tscherter A., Bracci E., Erbs E., Tognazzi N., Bernardi G., Pisani A., Calabresi P., Borrelli E. Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum. Neurosci 2004, 129:157-166.
6. Chen R., Zhang M., Park S., Gnegy M.E. C57BL/6J mice show greater amphetamine-induced locomotor activation and dopamine efflux in the striatum than 129S2/SvHsd mice. Pharmacol Biochem Behav 2007, 87:158-163.
7. Colelli V., Fiorenza M.T., Conversi D., Orsini C., Cabib S. Strain-specific proportion of the two isoforms of the dopamine D2 receptor in the mouse striatum: associated neural and behavioral phenotypes. Genes Brain Behav 2010, 9:703-711.
8. Darke S., Kaye S., McKetin R., Duflou J. Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev 2008, 27:253-262.
9. Davidson C., Gow A.J., Lee T.H., Ellinwood E.H. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res Brain Res Rev 2001, 36:1-22.
10. Deng X., Wang Y., Chou J., Cadet J.L. Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method. Brain Res Mol Brain Res 2001, 93:64-69.
11. Deng X., Cai N.S., McCoy M.T., Chen W., Trush M.A., Cadet J.L. Methamphetamine induced apoptosis in an immortalized rat striatal cell line by activating the mitochondrial cell death pathway. Neuropharmacology 2002, 42:837-845.
12. Egashira T., Yamanaka Y. Changes in monoamine oxidase activity in mouse brain associated with d-methamphetamine dependence and withdrawal. Biochem Pharmacol 1993, 46:609-614.
13. Erwin V.G., Womer D.E., Campbell A.D., Jones B.C. Pharmacogenetics of cocaine: II. Mesocorticolimbic and striatal dopamine and cocaine receptors in C57BL and DBA mice. Pharmacogenetics 1993, 3:189-196.
14. Fumagalli F., Gainetdinov R.R., Valenzano K.J., Caron M.G. Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter. J Neurosci 1998, 18:4861-4869.
15. Giordano T.P., Satpute S.S., Striessnig J., Kosofsky B.E., Rajadhyaksha A.M. Up-regulation of dopamine D2L mRNA levels in the ventral tegmental area and dorsal striatum of amphetamine-sensitized C57BL/6 mice: role of Cav1.3 L-type Ca2+ channels. J Neurochem 2006, 99:1197-1206.
16. Good R.L., Radcliffe R.A. Methamphetamine-induced locomotor changes are dependent on age, dose and genotype. Pharmacol Biochem Behav 2011, 98:101-111.
17. Granado N., Ares-Santos S., Oliva, OóShea E., Martin E.D., Colado M.I., Moratalla R. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA. Neurobiol Disease 2011, 42:391-403.
18. Grisel J.E., Belknap J.K., O'Toole L.A., Helms M.L., Wenger C.D., Crabbe J.C. Quantitative trait loci affecting methamphetamine responses in BXD recombinant inbred mouse strains. J Neurosci 1997, 17:745-754.
19. Harris D., Batki S.L. Stimulant psychosis: symptom profile and acute clinical course. Am J Addict 2000, 9:28-37.
20. He M., Shippenberg T.S. Strain differences in basal and cocaine-evoked dopamine dynamics in mouse striatum. J Pharmacol Exp Ther 2000, 293:121-127.
21. Imam S.Z., Ali S.F. Aging increases the susceptibility to methamphetamine-induced dopaminergic neurotoxicity in rats: correlation with peroxynitrite production and hyperthermia. J Neurochem 2001, 78:952-959.
22. Imam S.Z., el-Yazal J., Newport G.D., Itzhak Y., Cadet J.L., Slikker W., Ali S.F. Methamphetamine-induced dopaminergic neurotoxicity: role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts. Ann NY Acad Sci 2001, 939:366-380.
23. Jayanthi S., Deng X., Noailles P.H., Ladenheim B., Cadet J.L. Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochondria-dependent death cascades. FASEB J 2004, 18:238-251.
24. Johnason C.E., Frey K.A., Lundahl L.H., Keenan P., Lockhart N., Roll J., Galloway G.P., Koeppe R.A., Kilbourn M.R., Robbins T., Schuster C.R. Cognitive function and nigrostriatal markers in abstinent methamphetamine users. Psychopharmacology (Berl) 2006, 185:327-338.
25. Jones B.C., Tarantino L.M., Rodriguez L.A., Reed C.L., McClearn G.E., Plomin R., Erwin V.G. Quantitative-trait loci analysis of cocaine-related behaviours and neurochemistry. Pharmacogenetics 1999, 9:607-617.
26. Kanes S.J., Hitzemann B.A., Hitzemann R.J. On the relationship between D2 receptor density and neuroleptic-induced catalepsy among eight inbred strains of mice. J Pharmacol Exp Ther 1993, 267:538-547.
27. Kokoshka J.M., Fleckenstein A.E., Wilkins D.G., Hanson G.R. Age-dependent differential responses of monoaminergic systems to high doses of methamphetamine. J Neurochem 2000, 75:2095-2102.
28. Krasnova I.N., Hodges A.B., Ladenheim B., Rhoades R., Phillip C.G., Cesena A., Ivanova E., Hohmann C.F., Cadet J.L. Methamphetamine treatment causes delayed decrease in novelty-induced locomotor activity in mice. Neurosci Res 2009, 65:160-165.
29. Kuribara H., Tadokoro S. Reverse tolerance to ambulation-increasing effects of methamphetamine and morphine in 6 mouse strains. Jpn J Pharmacol 1989, 49:197-203.
30. Liang L.P., Patel M. Iron-sulfur enzyme mediated mitochondrial superoxide toxicity in experimental Parkinson's disease. J Neurochem 2004, 90:1076-1084.
31. Lindgren N., Usiello A., Goiny M., Haycock J., Erbs E., Greengard P., Hökfelt T., Borrelli E., Fisone G. Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites. Proc Natl Acad Sci USA 2003, 100:4305-4309.
32. Miller D.B., O'Callaghan J.P., Ali S.F. Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure. Ann NY Acad Sci 2000, 914:194-207.
33. Ng G.Y., O'Dowd B.F., George S.R. Genotypic differences in brain dopamine receptor function in the DBA/2J and C57BL/6J inbred mouse strains. Eur J Pharmacol 1994, 269:349-364.
34. Pereira F.C., Lourenco E.S., Borges F., Morgadinho T., Ribeiro C.F., Macedo T.R., Ali S.F. Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen. Synapse 2006, 60:185-193.
35. Phillips T.J., Dickinson S., Burkart-Kasch S. Behavioral sensitization to drug stimulant effects in C57BL/6J and DBA/2J inbred mice. Behav Neurosci 1994, 108:789-803.
36. Pubill D., Chipana C., Camins A., Pallas M., Camarasa J., Escubedo E. Free radical production induced by methamphetamine in rat striatal synaptosomes. Toxicol Appl Pharmacol 2005, 204:57-68.
37. Substance Abuse and Mental Health Services Administration (SAMHSA). (2006) Results from the 2005 National Survey on Drug Use and Health. NSDUH Series H-30. DHHS Pub No. SMA 06-4194, Rockville, MD: DHHS.
38. Sulzer D., Sonders M.S., Poulsen N.W., Gallia A. Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 2005, 75:406-433.
39. Suzuki O., Hattori H., Asano M., Oya M., Katsumata Y. Inhibition of monoamine oxidase by d-methamphetamine. Biochem Pharmacol 1980, 29:2071-2073.
40. Truong J.G., Wilkins D.G., Baudys J., Crouch D.J., Johnson-Davis K.L., Gibb J.W., Hanson G.R., Fleckenstein A.E. Age-dependent methamphetamine-induced alterations in vesicular monoamine transporter-2 function: implications for neurotoxicity. J Pharmacol Exp Ther 2005, 314:1087-1092.
41. Usiello A., Baik J.H., Rougé-Pont F., Picetti R., Dierich A., LeMeur M., Piazza P.V., Borrelli E. Distinct functions of the two isoforms of dopamine D2 receptors. Nature 2000, 408:199-203.
42. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Franceschi D., Sedler M., Gatley S.J., Miller E., Hitzemann R., Ding Y.S., Logan J. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci 2001, 21:9414-9418.
43. Wagner G.C., Ricaurte G.A., Seiden L.S., Schuster C.R., Miller R.J., Westley J. Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res 1980, 181:151-160.
44. Yamamoto B.K., Zhu W. The effects of methamphetamine on the production of free radicals and oxidative stress. J Pharmacol Exp Ther 1998, 287:107-114.
45. Yoo J.H., Bailey A., Ansonoff M., Pintar J.E., Matifas A., Kieffer B.L., Kitchen I. Lack of genotype effect on D1, D2 receptors and dopamine transporter binding in triple MOP-, DOP-, and KOP-opioid receptor knockout mice of three different genetic backgrounds. Synapse 2010, 64:520-527.
46. Zhu J.P.Q., Xu W., Angulo J.A. Disparity in the temporal appearance of methamphetamine induced apoptosis and depletion of dopamine terminal markers in the striatum of mice. Brain Res 2005, 1049:171-181.